Ruby Lu |

Ms. Ruby Lu has served as our independent Director since October 2016. She is a venture capitalist investing in technology start-ups in the U.S. and China. Ms. Lu founded Atypical Ventures, an early-stage technology venture investment firm, in 2019. In 2006, she co-founded DCM China, a venture capital firm. During her more than 12-year tenure at DCM, she invested in, and served as a board member for, many leading technology companies. Prior to joining DCM in 2003, Ms. Lu was a vice president in the investment banking group of technology, media and telecommunications at Goldman Sachs & Co. in Menlo Park, California. She served as chairman of the special committee and a member of the audit committee of iKang Healthcare Group, Inc. before it was taken private. She is currently an independent director on the board of Uxin Limited (NASDAQ: UXIN), where she also serves as the chairman of the compensation committee and a member of the audit committee and nominating and corporate governance committee. Ms. Lu obtained her Master of Arts from Johns Hopkins University in 1996. She brings to our Board public company board experience as well as extensive financial and global market experience.